These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2823652)

  • 21. Prednisone inhibits late asthmatic reactions and airway inflammation induced by toluene diisocyanate in sensitized subjects.
    Boschetto P; Fabbri LM; Zocca E; Milani G; Pivirotto F; Dal Vecchio A; Plebani M; Mapp CE
    J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):261-7. PubMed ID: 3040835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of nifedipine upon specific bronchial responses to isocyanates.
    Moscato G; Gherson G; Biscaldi G; Candura F
    G Ital Med Lav; 1983 Nov; 5(6):247-50. PubMed ID: 6100488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Occupational toluene diisocyanate (TDI) asthma--inhalation challenge test and TDI-HSA (human serum albumin) skin test and detection of specific IgE].
    Duan YY
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Jun; 12(3):149-52, 191. PubMed ID: 2553281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific bronchial reactivity to toluene diisocyanate: dose-response relationship.
    Paggiaro PL; Lastrucci L; Pardi F; Rossi O; Bacci E; Talini D
    Respiration; 1986; 50(3):167-73. PubMed ID: 3025984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late asthmatic reactions and changes in histamine responsiveness provoked by occupational agents.
    Graneek BJ; Durham SR; Newman Taylor AJ
    Bull Eur Physiopathol Respir; 1987; 23(6):577-81. PubMed ID: 2840138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TDI-induced oculorhinitis and bronchial asthma.
    Paggiaro PL; Rossi O; Lastrucci L; Pardi F; Pezzini A; Baschieri L
    J Occup Med; 1985 Jan; 27(1):51-2. PubMed ID: 2982003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway inflammation during late asthmatic reactions induced by toluene diisocyanate.
    Fabbri LM; Maestrelli P; Saetta M; Mapp CE
    Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S37-8. PubMed ID: 1848414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI).
    Maestrelli P; Occari P; Turato G; Papiris SA; Di Stefano A; Mapp CE; Milani GF; Fabbri LM; Saetta M
    Clin Exp Allergy; 1997 Nov; 27(11):1292-8. PubMed ID: 9420133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant changes of bronchial responsiveness to methacholine after early asthmatic reaction to toluene diisocyanate (TDI) in a TDI-sensitive asthmatic worker.
    Park HS; Cho YS; Park JN; Baik JH; Rhu NS; Cho DI; Kim JW
    J Korean Med Sci; 1990 Dec; 5(4):185-8. PubMed ID: 1966034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure.
    Pisati G; Baruffini A; Zedda S
    Br J Ind Med; 1993 Jan; 50(1):60-4. PubMed ID: 8381658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late asthmatic reactions, airway inflammation and chronic asthma in toluene-diisocyanate-sensitized subjects.
    Fabbri LM; Saetta M; Picotti G; Mapp CE
    Respiration; 1991; 58 Suppl 1():18-21. PubMed ID: 1656502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late asthmatic reactions, airway inflammation and chronic asthma in TDI sensitized subjects.
    Fabbri LM; Picotti G; Mapp CE
    Eur Respir J Suppl; 1991 Apr; 13():136s-138s. PubMed ID: 1659425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic asthma due to toluene diisocyanate.
    Moller DR; Brooks SM; McKay RT; Cassedy K; Kopp S; Bernstein IL
    Chest; 1986 Oct; 90(4):494-9. PubMed ID: 3019611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge.
    Scheerens H; Buckley TL; Muis TL; Garssen J; Dormans J; Nijkamp FP; Van Loveren H
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1074-80. PubMed ID: 10194148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects.
    Saetta M; Maestrelli P; Turato G; Mapp CE; Milani G; Pivirotto F; Fabbri LM; Di Stefano A
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):489-94. PubMed ID: 7842211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse.
    Scheerens H; Buckley TL; Davidse EM; Garssen J; Nijkamp FP; Van Loveren H
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):858-65. PubMed ID: 8887575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theophylline inhibits late asthmatic reactions induced by toluene diisocyanate in sensitised subjects.
    Crescioli S; De Marzo N; Boschetto P; Spinazzi A; Plebani M; Mapp CE; Fabbri LM; Ciaccia A
    Eur J Pharmacol; 1992 May; 228(1):45-50. PubMed ID: 1327850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occupational asthma, lung function decrement, and toluene diisocyanate (TDI) exposure: a critical review of exposure-response relationships.
    Ott MG
    Appl Occup Environ Hyg; 2002 Dec; 17(12):891-901. PubMed ID: 12495600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up study of patients with respiratory disease due to toluene diisocyanate (TDI).
    Paggiaro PL; Loi AM; Rossi O; Ferrante B; Pardi F; Roselli MG; Baschieri L
    Clin Allergy; 1984 Sep; 14(5):463-9. PubMed ID: 6091946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil chemotactic activity in toluene diisocyanate (TDI)-induced asthma.
    Sastre J; Banks DE; Lopez M; Barkman HW; Salvaggio JE
    J Allergy Clin Immunol; 1990 Mar; 85(3):567-72. PubMed ID: 2155957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.